Safety of Flecainide and Propafenone in Patients With Atrial Fibrillation and Structural Heart Disease
{{output}}
Background: Class Ic antiarrhythmic drugs (AADs) have been contraindicated in patients with structural heart disease since the 1991 Cardiac Arrhythmia Suppression Trial (CAST), which demonstrated increased mortality in post-myoca... ...
